Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease.

Therapeutics

Thymmune Therapeutics

The Cambridge office focuses on scientific research and regulatory affairs, particularly in immunology and technology innovation.

Cambridge

Stan Wang, MD, PhD

Thomas McGeggen

Lauren Demayo Trainor

Manish Jain

Bing Lim, MD, PhD

This department focuses on scientific innovation and development of new technologies.

Research and Development

This department focuses on overseeing operational processes and advancing analytical development initiatives.

Operations and Development

This department focuses on conducting research and analysis to support the organization's objectives.

Research Department

This department sets the strategic direction and oversees the overall operations of the organization.

Executive Leadership

This department focuses on research and development in the field of immunology.

Immunology Department

This department oversees process development and financial strategy within the organization.

Thymmune Therapeutics

Org chart

Teams

Research and Development

Operations and Development

Research Department

Executive Leadership

Immunology Department

Process and Finance

Offices

Thymmune Therapeutics

Org chart

Teams

Research and Development

Operations and Development

Research Department

Executive Leadership

Immunology Department

Process and Finance

Offices

Related companies